Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (727)
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
409
Price
$292.82
Total Value
$119.76K
Shares Held After
41,514
% of Holdings
1.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
991
Price
$291.71
Total Value
$289.09K
Shares Held After
41,923
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
200
Price
$290.60
Total Value
$58.12K
Shares Held After
42,914
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
503
Price
$289.80
Total Value
$145.77K
Shares Held After
43,114
% of Holdings
1.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
356
Price
$288.75
Total Value
$102.79K
Shares Held After
43,617
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,214
Price
$287.77
Total Value
$349.36K
Shares Held After
43,973
% of Holdings
2.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,032
Price
$286.80
Total Value
$295.97K
Shares Held After
45,187
% of Holdings
2.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
157
Price
$285.74
Total Value
$44.86K
Shares Held After
46,219
% of Holdings
0.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
33
Price
$284.55
Total Value
$9.39K
Shares Held After
46,376
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
105
Price
$284.14
Total Value
$29.83K
Shares Held After
46,409
% of Holdings
0.2%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
15,000
Price
$8.02
Total Value
$120.24K
Shares Held After
1,676,126
% of Holdings
0.9%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$8.01
Total Value
$133.55K
Shares Held After
1,144,462
% of Holdings
1.4%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.09
Total Value
$61.35K
Shares Held After
1,154,327
% of Holdings
1.3%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
12,415
Price
$10.05
Total Value
$124.72K
Shares Held After
871,737
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$518.61
Total Value
$165.96K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,220
Price
$517.49
Total Value
$631.33K
Shares Held After
324,763
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,075
Price
$516.49
Total Value
$1.07M
Shares Held After
325,983
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,218
Price
$515.73
Total Value
$2.18M
Shares Held After
328,058
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,667
Price
$514.83
Total Value
$858.23K
Shares Held After
332,276
% of Holdings
0.5%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
6,055
Price
$120.43
Total Value
$729.20K
Shares Held After
61,441
% of Holdings
9.0%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
10,000
Price
$9.58
Total Value
$95.80K
Shares Held After
131,633
% of Holdings
7.1%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,696
Price
$24.92
Total Value
$117.02K
Shares Held After
96,295
% of Holdings
4.6%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
1,900
Price
$24.92
Total Value
$47.35K
Shares Held After
92,562
% of Holdings
2.0%
Alkermes plc. (ALKS)
snyderman nancy lynn MD — Director
Shares
44,472
Price
$50.35
Total Value
$2.24M
Shares Held After
15,395
% of Holdings
74.3%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$48.58
Total Value
$98.81K
Shares Held After
225,456
% of Holdings
0.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$48.58
Total Value
$437.22K
Shares Held After
69,389
% of Holdings
11.5%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
33,772
Price
$6.50
Total Value
$219.52K
Shares Held After
497,751
% of Holdings
6.4%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.01
Total Value
$40.03K
Shares Held After
17,217
% of Holdings
12.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
16,589
Price
$23.05
Total Value
$382.36K
Shares Held After
9,110
% of Holdings
64.6%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,293
Price
$119.41
Total Value
$273.81K
Shares Held After
61,441
% of Holdings
3.6%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
326
Price
$121.69
Total Value
$39.67K
Shares Held After
63,734
% of Holdings
0.5%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
85
Price
$122.19
Total Value
$10.39K
Shares Held After
64,060
% of Holdings
0.1%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
1,642
Price
$119.38
Total Value
$196.02K
Shares Held After
64,145
% of Holdings
2.5%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
1,643
Price
$119.51
Total Value
$196.35K
Shares Held After
65,787
% of Holdings
2.4%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,864
Price
$119.40
Total Value
$341.96K
Shares Held After
67,430
% of Holdings
4.1%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
4,695
Price
$119.39
Total Value
$560.54K
Shares Held After
70,294
% of Holdings
6.3%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
6,171
Price
$119.43
Total Value
$737.00K
Shares Held After
74,989
% of Holdings
7.6%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,187
Price
$119.47
Total Value
$261.28K
Shares Held After
81,160
% of Holdings
2.6%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
5,332
Price
$119.42
Total Value
$636.75K
Shares Held After
83,347
% of Holdings
6.0%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
14,661
Price
$119.46
Total Value
$1.75M
Shares Held After
88,679
% of Holdings
14.2%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
15,888
Price
$119.70
Total Value
$1.90M
Shares Held After
215,444
% of Holdings
6.9%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
238
Price
$522.88
Total Value
$124.44K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
282
Price
$521.52
Total Value
$147.07K
Shares Held After
324,681
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,517
Price
$520.80
Total Value
$790.06K
Shares Held After
324,963
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,627
Price
$520.12
Total Value
$1.37M
Shares Held After
326,480
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,266
Price
$519.06
Total Value
$657.12K
Shares Held After
329,107
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$518.00
Total Value
$629.37K
Shares Held After
330,373
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,133
Price
$516.94
Total Value
$585.70K
Shares Held After
331,588
% of Holdings
0.3%
Showing 1–50 of 727 transactions (page 1 of 15)